×
Home Current Archive Editorial board
News Contact
Proof of Concept

Digitized Maternal Early Warning and Response Telehealth System

By
Narmadha Kuppuswami Orcid logo ,
Narmadha Kuppuswami
Suresh Subramanian ,
Suresh Subramanian
Karenna J. Groff ,
Karenna J. Groff
Radha Rani Ravichandran
Radha Rani Ravichandran

Abstract

Introduction: In this article, we describe a pilot telehealth project for identifying women at risk of developing serious complications early and for instituting timely, appropriate, and up-to-date management even in situations with limited resources and skilled obstetric services. Maternal mortality remains unacceptably high, with less than two-thirds of the signatories to the 2015 Millennium Development Goals achieving the outlined 75% reduction in maternal mortality ratio (MMR) from 1990 to 2015. Looking forward to 2030, the Sustainable Development Goals (SDGs) lay out a target of reducing the MMR in every country to below 70 per 100,000 live births. This will require progress in low-and-middle-income countries at a rate much greater than that seen over the past 15 years. Given that 94% of the global maternal deaths occur in low- and-middle-income countries, a solution to meet the unique challenges of these countries will be necessary to achieve the SDG. The Women’s Obstetrical Neonatal Death and Reduction (WONDER) telehealth system described here offers a potential telehealth solution to reduce mortality and morbidity rates in resource-limited environments by early identification of risk indicators and initiation of care. Materials and methods: The WONDER system consists of a cloud-based electronic health record with a Clinical Decision Support tool and a color-coded alert system. The Clinical Decision Support tool is based upon Maternal Early Warning Signs and provides real-time assistance to caregivers via relevant national treatment guidelines. This system uses inexpensive computing hardware, displays, and cell-phone technology. This system was tested in a 2-year pilot study in India. A total of 15,184 patients were monitored during labor and the postpartum period. Results: Within limitations of the study, the incidence of in-hospital eclampsia was reduced by 91.7%, and in 95% of cases, timely treatment was started within an hour of identifying the abnormality in vital signs. Maternal mortality was reduced by 50.1% over local benchmark figures. Conclusions: The WONDER system identified at-risk patients, directed skilled care to those patients at risk for complications, and helped to institute effective, timely treatment, demonstrating a potential solution for women in resource-limited locations.

References

1.
Maternal mortality facts sheet. 2019;
2.
Stanton ME, Kwast BE, Shaver T, McCallon B, Koblinsky M. Beyond the Safe Motherhood Initiative: Accelerated Action Urgently Needed to End Preventable Maternal Mortality. Global Health: Science and Practice. 2018;6(3):408–12.
3.
Alkema L, Chou D, Hogan D, Zhang S, Moller AB, Gemmill A, et al. Global, regional, and national levels and trends in maternal mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the UN Maternal Mortality Estimation Inter-Agency Group. The Lancet. 2016;387(10017):462–74.
4.
Statistics Divisions. The sustainable development goals report. 2020;
5.
United Nations. 2015;
6.
India has achieved groundbreaking success in reducing maternal mortality.
7.
Kanti V, Sharma P, Seth S. Maternal Mortality Trends in Rural Uttar Pradesh, India: A 6-year Retrospective Study at a Tertiary Care Institution. Journal of SAFOG with DVD. 2017;9(4(Supplement)):372–6.
8.
Mukherjee S, Mukherjee S, Sarkar R. A six year retrospective study of maternal mortality at a tertiary teaching institute in Uttarpradesh. International Journal of Medical Science and Public Health. 2014;3(11):1407.
9.
Barnes-Josiah D, Myntti C, Augustin A. The “three delays” as a framework for examining maternal mortality in Haiti. Social Science & Medicine. 1998;46(8):981–93.
10.
Pacagnella RC, Cecatti JG, Osis MJ, Souza JP. The role of delays in severe maternal morbidity and mortality: expanding the conceptual framework. Reproductive Health Matters. 2012;20(39):155–63.
11.
Chavane LA, Bailey P, Loquiha O, Dgedge M, Aerts M, Temmerman M. Maternal death and delays in accessing emergency obstetric care in Mozambique. BMC Pregnancy and Childbirth. 2018;18(1).
12.
Lassi Z, Salam R, Das J, Ali A, Bhaumik S. Diagnosis and management of preeclampsia in community settings in low and middle-income countries. Journal of Family Medicine and Primary Care. 2015;4(4):501.
13.
Shennan AH, Redman C, Cooper C, Milne F. Are most maternal deaths from pre-eclampsia avoidable? The Lancet. 2012;379(9827):1686–7.
14.
ACOG Committee on Obstetric Practice. Practice bulletin #33: diagnosis and management of preeclampsia and eclampsia. Obstetrics & Gynecology. 2002;99(1):159–67.
15.
Gupte S, Wagh G. Preeclampsia–Eclampsia. The Journal of Obstetrics and Gynecology of India. 2014;64(1):4–13.
16.
Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional estimates of preeclampsia and eclampsia: a systematic review. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2013;170(1):1–7.
17.
Gestational Hypertension and Preeclampsia. Obstetrics & Gynecology. 2020;135(6):e237–60.
18.
Nobis PN, Hajong A. Eclampsia in India Through the Decades. The Journal of Obstetrics and Gynecology of India. 2016;66(S1):172–6.
19.
Vousden N, Lawley E, Seed PT, Gidiri MF, Goudar S, Sandall J, et al. Incidence of eclampsia and related complications across 10 low- and middle-resource geographical regions: Secondary analysis of a cluster randomised controlled trial. PLOS Medicine. 2019;16(3):e1002775.
20.
Nour N. An introduction to maternal mortality. Rev Obstet Gynecol. 2008;(2):77–81.
21.
India HMIS standard report-Data itemwise monthly 2017-2018. 2018;
22.
Josephine S. Tamil Nadu’s maternal mortality rate sees sharp six-point drop. The Hindu.
23.
Emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period.

Citation

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.